ANI Pharmaceuticals, Inc. (ANIP): Price and Financial Metrics

ANI Pharmaceuticals, Inc. (ANIP): $56.87

1.19 (-2.05%)

POWR Rating

Component Grades








Add ANIP to Watchlist
Sign Up

Industry: Biotech




#41 of 356

in industry

ANIP Price/Volume Stats

Current price $56.87 52-week high $65.89
Prev. close $58.06 52-week low $31.21
Day low $55.90 Volume 230,400
Day high $57.66 Avg. volume 120,421
50-day MA $59.33 Dividend yield N/A
200-day MA $47.64 Market Cap 1.15B

ANIP Stock Price Chart Interactive Chart >


  • Growth is the dimension where ANIP ranks best; there it ranks ahead of 98.52% of US stocks.
  • ANIP's strongest trending metric is Quality; it's been moving up over the last 177 days.
  • ANIP's current lowest rank is in the Momentum metric (where it is better than 9.63% of US stocks).

ANIP Stock Summary

  • The price/operating cash flow metric for ANI PHARMACEUTICALS INC is higher than 86.21% of stocks in our set with a positive cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, ANI PHARMACEUTICALS INC is reporting a growth rate of -130.46%; that's higher than just 10.83% of US stocks.
  • As for revenue growth, note that ANIP's revenue has grown 59.71% over the past 12 months; that beats the revenue growth of 91.03% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ANI PHARMACEUTICALS INC are KLR, EVCM, XMTR, SWI, and VISL.
  • ANIP's SEC filings can be seen here. And to visit ANI PHARMACEUTICALS INC's official web site, go to

ANIP Valuation Summary

  • ANIP's EV/EBIT ratio is 68.9; this is 493.97% higher than that of the median Healthcare stock.
  • Over the past 243 months, ANIP's EV/EBIT ratio has gone up 79.6.

Below are key valuation metrics over time for ANIP.

Stock Date P/S P/B P/E EV/EBIT
ANIP 2023-09-22 3.0 2.9 -175.0 68.9
ANIP 2023-09-21 3.0 2.9 -177.4 69.8
ANIP 2023-09-20 3.1 3.0 -181.0 71.1
ANIP 2023-09-19 3.1 3.0 -182.7 71.7
ANIP 2023-09-18 3.1 3.0 -183.7 72.0
ANIP 2023-09-15 3.2 3.1 -186.6 73.1

ANIP Growth Metrics

    The 4 year price growth rate now stands at -32%.
  • The 3 year cash and equivalents growth rate now stands at 89.43%.
  • Its 3 year net cashflow from operations growth rate is now at -162.1%.
Over the past 67 months, ANIP's revenue has gone up $138,387,000.

The table below shows ANIP's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 283.082 -38.988 -69.197
2022-06-30 251.322 -48.013 -64.638
2022-03-31 226.092 -36.288 -63.414
2021-12-31 216.136 3.322 -42.793
2021-09-30 212.459 9.798 -22.102
2021-06-30 213.377 13.586 -17.221

ANIP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ANIP has a Quality Grade of D, ranking ahead of 9.89% of graded US stocks.
  • ANIP's asset turnover comes in at 0.453 -- ranking 96th of 682 Pharmaceutical Products stocks.
  • NWBO, CYTR, and NAII are the stocks whose asset turnover ratios are most correlated with ANIP.

The table below shows ANIP's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.453 0.570 -0.047
2021-06-30 0.457 0.592 -0.029
2021-03-31 0.460 0.600 -0.018
2020-12-31 0.446 0.582 -0.047
2020-09-30 0.427 0.596 -0.063
2020-06-30 0.425 0.619 -0.054

ANIP Price Target

For more insight on analysts targets of ANIP, see our ANIP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $45.00 Average Broker Recommendation 1.75 (Moderate Buy)

ANI Pharmaceuticals, Inc. (ANIP) Company Bio

ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The company was founded in 2004 and is based in Baudette, Minnesota.

ANIP Latest News Stream

Event/Time News Detail
Loading, please wait...

ANIP Latest Social Stream

Loading social stream, please wait...

View Full ANIP Social Stream

Latest ANIP News From Around the Web

Below are the latest news stories about ANI PHARMACEUTICALS INC that investors may wish to consider to help them evaluate ANIP as an investment opportunity.

ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should Know

ANI Pharmaceuticals (ANIP) closed at $58.06 in the latest trading session, marking a -1.41% move from the prior day.

Yahoo | September 29, 2023

Mirati (MRTX) Soars 12.3%: Is Further Upside Left in the Stock?

Mirati (MRTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Yahoo | September 22, 2023

ANI Pharmaceuticals (ANIP) Stock Moves -0.9%: What You Should Know

ANI Pharmaceuticals (ANIP) closed at $60.53 in the latest trading session, marking a -0.9% move from the prior day.

Yahoo | September 20, 2023

ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor Global Healthcare Conference 2023 in New York City as follows: Date: Tuesday, September 26, 2023 Time: 11:40am ET Webcast: Click here To schedule a 1x1 meeting with the Company, please contact [email protected]. The live and archived webcast wi

Yahoo | September 18, 2023

ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, ANI Pharmaceuticals (ANIP) closed at $63.61, marking a +1.26% move from the previous day.

Yahoo | September 14, 2023

Read More 'ANIP' Stories Here

ANIP Price Returns

1-mo -11.94%
3-mo N/A
6-mo 48.18%
1-year 76.94%
3-year 98.92%
5-year 0.98%
YTD 41.36%
2022 -12.70%
2021 58.68%
2020 -52.91%
2019 36.98%
2018 -30.15%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!